One Dose of Ad5-nCoV , a #COVID19 Vaccine Developed in #China, is 57.5% ... - Latest Tweet by IANS India

One dose of Ad5-nCoV (Convidecia), a #COVID19 vaccine developed in #China, is 57.5% effective against symptomatic Covid-19 and 91.7% effective against severe Covid-19 disease beginning 28 days post-vaccination, finds a new study. pic.twitter.com/uezqJxauJ2— IANS Tweets (@ians_india) December 25, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)